Stay updated with breaking news from Arctoris Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Marketresearch.biz reports that the Generative AI in Pharma market size is expected to be worth around USD 2258.1 Mn by 2033 from USD 159.9 Mn in 2023, growing at a CAGR of 31.2% during the forecast period from 2024 to 2033.Overview of the Generative AI in Pharma MarketGenerative AI in pharma revolutionizes drug dis...
/PRNewswire/ -- The "Drug Discovery Services Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Arctoris Ltd, a tech-enabled biopharma platform company, has appointed three globally recognized experts in Alzheimer's disease, Machine Learning applied to closed loop discovery, and automated chemistry
Cyclica Inc. ("Cyclica"), a neo-biotech with the vision to advance the most robust and sustainable drug discovery pipeline, and Arctoris Ltd. ("Arctoris"), a tech-enabled biopharma company that combines
Through end-to-end automation, the company’s unique technology platform rapidly delivers reliable, reproducible, and fully auditable datasets Arctoris Ltd Ulysses is an advanced, fully automated robotic platform developed and operated by Arctoris that provides superior quality data and accelerates drug discovery. February 24, 2021 OXFORD, UK — February 10, 2021 — Life Science Newswire — Arctoris Ltd, an Oxford-based technology company operating a fully automated drug discovery platform, celebrated its fifth anniversary on Feb. 4. Over the past five years, Arctoris has grown from a te...